04/25/2024 3:01 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 7:06 PM | Brainstorm Cell Therapeutics (Issuer) Dagher Ibrahim B. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/19/2024 5:05 AM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 8:31 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/11/2024 5:10 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2024 5:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 3:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
04/01/2024 8:16 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
04/01/2024 7:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 7:54 PM | Brainstorm Cell Therapeutics (Issuer) Lebovits Chaim (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 7:55 PM | Brainstorm Cell Therapeutics (Issuer) Patlis Alla (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 7:56 PM | Brainstorm Cell Therapeutics (Issuer) Yablonka Uri (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 7:57 PM | Brainstorm Cell Therapeutics (Issuer) Lindborg Stacy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 9:06 AM | Brainstorm Cell Therapeutics (Subject) Ness Kevin Dean (Filed by)
| Form SC 13G/A | |
12/20/2023 4:04 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/22/2023 5:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 3:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 4:28 PM | Brainstorm Cell Therapeutics (Filer)
| Form DEF 14A | |
10/24/2023 6:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2023 4:16 PM | Brainstorm Cell Therapeutics (Issuer) Lindborg Stacy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 6:31 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023 6:31 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023 6:21 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2023 5:02 AM | Brainstorm Cell Therapeutics (Issuer) Lindborg Stacy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2023 8:28 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5 | |
06/21/2023 3:05 PM | Brainstorm Cell Therapeutics (Issuer) Naor Nir (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/21/2023 3:06 PM | Brainstorm Cell Therapeutics (Issuer) Naor Nir (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2023 7:58 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2023 6:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2023 6:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |